Royal Canin names Jennifer Cullen to lead U.S. veterinary unit
Bottom line
Royal Canin North America has named Jennifer Cullen general manager of its U.S. Veterinary Business Unit, effective June 2026, according to Pet Age. Cullen joins the Mars-owned nutrition company after senior commercial roles at Kenvue and Johnson & Johnson, bringing a background in consumer health and brand leadership as Royal Canin continues to invest in its veterinary channel and therapeutic nutrition portfolio. The move appears to mark another leadership transition for the business unit, which Royal Canin said in July 2024 was led by Heather Pasquale. (prnewswire.com)
Why it matters: Royal Canin’s U.S. veterinary business sits at the intersection of clinic nutrition recommendations, therapeutic diet sales, client education, and industry partnerships. For veterinary professionals, a new business-unit leader can shape how aggressively the company expands practice support, continuing education, product access, and nutrition-focused tools for teams counseling pet parents about obesity, renal disease, GI disease, and other diet-sensitive conditions. Royal Canin has recently emphasized veterinary education and research partnerships, including its renewed agreement with the University of Tennessee Veterinary Obesity Center and its Academy resources for veterinarians and technicians. (prnewswire.com)
What to watch: Watch for an official Royal Canin announcement, any changes in channel strategy or veterinary partnerships, and clues about whether Cullen’s appointment signals a broader push in therapeutic nutrition, digital practice support, or both. (royalcanin.com)
Royal Canin North America has appointed Jennifer Cullen as general manager of its U.S. Veterinary Business Unit, effective June 2026, according to Pet Age. The appointment puts a longtime consumer health executive into a key leadership role at one of the most influential companies in veterinary nutrition, with responsibility for a business tied closely to therapeutic diets, veterinary relationships, and practice-facing education. Pet Age reported that Cullen previously held roles at Kenvue and Johnson & Johnson and will focus on expanding Royal Canin’s veterinary business and therapeutic nutrition offerings for pets with specialized needs. (kenvue.com)
The move comes after a relatively recent change in the same seat. In July 2024, Royal Canin announced Heather Pasquale as general manager of the U.S. Vet Business Unit, effective July 1, 2024, after Pasquale’s work at Banfield and within Mars. At that time, Royal Canin said the role would focus on growing the veterinary business, strengthening customer relationships, expanding product offerings, and providing educational opportunities for veterinary partners. Cullen’s appointment suggests the company is again recalibrating leadership for a business unit that remains strategically important to both Royal Canin and the broader Mars pet care ecosystem. (prnewswire.com)
That broader context matters. Royal Canin remains deeply embedded in the veterinary channel through therapeutic diets, clinic partnerships, and professional education. In February 2026, the company promoted Kira Best to lead its Healthy Pet & Pet Specialty business, a separate North American portfolio focused on breed- and size-based nutrition, while reporting to Regional President Daryn Brown. The company has also continued to invest in veterinary-facing initiatives, including Royal Canin Academy content for veterinarians and technicians, the Pet Nutrition Advisor Program, and event visibility at VMX 2026. (prnewswire.com)
Royal Canin’s recent external messaging has also leaned heavily into clinical nutrition and preventive care. In March 2026, it renewed a multi-year agreement with the University of Tennessee Veterinary Obesity Center to support research and management of canine and feline obesity. Separately, Royal Canin has highlighted “healthspan” and midlife intervention as emerging themes in veterinary nutrition science, framing nutrition as a tool not just for disease management, but for earlier, longer-term health support. Those priorities line up with the kind of portfolio expansion Pet Age said Cullen will oversee. (prnewswire.com)
Publicly available background on Cullen points to a commercial leader with substantial experience in consumer health. Archived Johnson & Johnson materials identify her in prior leadership roles tied to OTC brands including Pepcid and Motrin, and a 2021 profile described her as a vice president in J&J Self-Care. Kenvue, which became fully independent from Johnson & Johnson in August 2023, has continued operating as a major consumer health company, although available public materials reviewed here did not surface an official Royal Canin press release confirming Cullen’s move by name. That means Pet Age may be ahead of Royal Canin’s own public announcement, or the company may have distributed the news through trade channels first. (jnj.com)
Why it matters: For veterinary professionals, leadership changes at Royal Canin can have practical downstream effects. The company’s veterinary business influences therapeutic diet availability, clinic education, technician training, obesity-management support, and how nutrition is positioned in everyday case work. If Cullen brings a stronger consumer-health commercialization lens, practices could see more emphasis on adherence tools, client communication, omnichannel support, and programs designed to help teams explain the role of nutrition to pet parents. At the same time, any push to grow the therapeutic portfolio could sharpen competition across the prescription and veterinary-exclusive diet category, with implications for clinic revenue, formulary choices, and client retention. (academy.royalcanin.com)
There’s also a bigger industry angle. Mars already spans nutrition, general practice, specialty care, diagnostics, and pet health services through brands including Royal Canin, Banfield, VCA, BluePearl, and Antech. That gives Royal Canin unusual visibility into how diets, clinical workflows, and pet parent behavior connect across the care journey. A new leader in the U.S. veterinary unit could use that ecosystem to deepen educational partnerships, refine product strategy, or expand digital tools that support nutrition conversations in practice. This is an inference based on Mars’ operating footprint and Royal Canin’s existing veterinary programs, rather than a stated plan from the company. (prnewswire.com)
What to watch: The next signals will be whether Royal Canin publishes a formal announcement, how it describes Cullen’s remit, and whether upcoming moves center on therapeutic diet launches, practice support programs, obesity and healthspan initiatives, or new veterinary partnerships in the second half of 2026. (royalcanin.com)